BSECompany Update2h ago · 22 Jul 2026, 03:45 pm

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

AstraZeneca Pharma India Ltd · 506820

✦ AI SummaryDividend

AstraZeneca Pharma India Ltd has announced that it will deduct tax at source on the final dividend for the financial year 2025-26, as per the Finance Act 2020. The dividend will be paid after deducting tax at source under section 393 of the Income Tax Act, 2025. Resident shareholders who do not have a PAN or have an invalid PAN will have 20% tax deducted, while those who provide a self-attested copy of PAN and meet other conditions may be exempt from tax. Non-resident shareholders will have 20% tax deducted, unless they provide a tax treaty benefit certificate.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

AstraZeneca Pharma India Ltd - 506820 - Communication To The Shareholders W.R.T. TDS On Dividend

Attachments (1)

📄

75735b43-7121-445c-8768-6c6e75139cb6.pdf

pdf

Download →
View document text
July 22, 2026 The Manager – Listing BSE Limited, P J Towers, Dalal Street, Fort, Mumbai 400001 The Manager – Listing National Stock Exchange of India Ltd. Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai 400051 Dear Sir/ Madam, Subject: Communication to the shareholders w.r.t. TDS on Dividend Pursuant to the recommendation of the Dividend by the Board of Directors of the Company at its Meeting held on May 26, 2026, the Company has sent the enclosed e-mail communication to its shareholders, with respect to the deduction of tax at source on Dividend for the financial year 2025-26, whose email addresses are registered with the Company/ Depository Participants. The specimen of the communication is appended herewith for your reference and records, and the same will also be available on the website of the Company at www.astrazeneca.com/india. We request you to kindly take the above on records. Thanking you, For AstraZeneca Pharma India Limited Tanya Sanish Company Secretary & Compliance Officer ACS No. 25784 Date: July 21, 2026 Subject: Deduction of tax at source with respect to Final Dividend recommended (subject to approval of shareholders at the 47th Annual General Meeting). Dear Shareholders, As you may be aware the Board of Directors of your Company have recommended a Final dividend of Rs. 36/- per share for the financial year 2025-26 at its Meeting held on May 26, 2026, subject to the approval of the Shareholders at the ensuing 47th Annual General Meeting scheduled to be held on Monday, August 10, 2026. The Company has fixed July 31, 2026 as the record date for determining entitlement of Shareholders to receive the final dividend. Pursuant to changes introduced in the Finance Act, 2020, dividends paid or distributed by a Company after 1st April 2020 shall be taxable in the hands of the shareholders. Rate at which dividend may be subject to withholding tax would vary depending on residential status of the shareholder and documents submitted by them and accepted by the Company. Accordingly, Final Dividend for FY 26 will be paid after deducting tax at source under section 393 of the Income Tax Act, 2025 (“the Act”) follows: Resident Shareholders It may be noted that tax would not be deducted at source on payment of dividend to resident individual shareholder, if total dividend amount to be paid in FY 27 does not exceed INR 10,000/-. Tax to be deducted at source for FY27, wherever applicable, would be as under: Particulars Applicable Documents required (if any) Rate Shareholders 10% Update PAN, and residential status as per Income Tax Act, having PAN 2025, if not already done, with Depositories (in case of shares held in demat mode) and with the Company's Registrar and Transfer Agent (RTA) (in case of shares held in physical mode). NIL Form 121 (erstwhile form 15G and form 15H), provided that all required eligibility conditions are met, and a self- attested copy of PAN is furnished. Shareholders not 20% - having/ furnished PAN/ Invalid PAN Shareholders Rate Lower/ NIL withholding tax certificate obtained from tax submitting the provided in authority along with self-attested copy of PAN. Order under the Order section 395(1) of the Act Shareholders (e.g. NIL Declaration that it has full beneficial interest with respect LIC, GIC) for to the shares owned by it along with self-attested copy of whom section PAN and registration certificate. 393(1) of the Act is not applicable Shareholders NIL Self-declaration that their income is exempt under section being Alternative 11 [schedule V] of the Act, and they are established as Investment Funds Category - I or Category - II AIF under the SEBI (AIFs) regulations along with self-attested copy of relevant registration documents and PAN. Shareholders NIL Certificate of registration under Schedule VII (Table: S. covered under No. 20) issued by the appropriate authority, self-attested Section 393(5) of copy of PAN, documentary evidence that the person is the Act (e.g. covered under said section 393(5) of the Act. Mutual Funds, Govt.) Resident individual shareholders are requested to ensure their Aadhar Number is linked with PAN, failing which, PAN shall be considered as inoperative/ invalid and hence, tax at 20% shall be deducted in such cases. Non-Resident Shareholders As per Section 159 of the Income Tax Act, 2025, non-resident shareholder has the option of being governed by the provisions of Double Tax Avoidance Treaty (DTAA) between India and country of tax residence of such shareholder, if they are more beneficial to them. Kindly refer to below-table for details of documents to avail Tax Treaty benefits. Particulars Applicable Rate Documents required (if any) Shareholders, 20% (plus applicable a) Registration copy of FII/ FPI being Foreign surcharge and cess) Institutional b) Self-attested copy of Permanent Account Investors (FIIs)/ OR Number (PAN) allotted by the Indian Income Foreign Tax authorities. Portfolio Tax Treaty Rate Investors (FPIs) (whichever is lower) c) Self-attested copy of Tax Residency Certificate (TRC) obtained from tax authorities of the country of which the shareholder is resident, valid on August 2026. d) Self-declaration in online Form 41. e) Self-declaration by non-resident shareholder about having no Permanent Establishment in India in accordance with the applicable Tax Treaty. f) Self-declaration of Beneficial ownership by non-resident shareholder. Other 20% (plus applicable a) Self-attested copy of the Permanent Account Non-resident surcharge and cess) Number (PAN) allotted by the Indian Income shareholders Tax authorities. b) Self-attested copy of Tax Residency Certificate Tax Treaty Rate (TRC) obtained from the tax authorities of the (whichever is lower) country of which the shareholder is resident, valid on August 2026. c) Self-declaration in online Form 41. d) Self-declaration by the non-resident shareholder about having no Permanent Establishment in India in accordance with the applicable Tax Treaty. e) Self-declaration of Beneficial ownership by non-resident shareholder. Section 395(1) Rate provided in the Lower/ NIL withholding tax certificate obtained of the Act Shareholders from tax authority. submitting Order under section Order In case, PAN is not available, the non-resident shareholder (other than a company) shall furnish (a) name, (b) email ID, (c) contact number, (d) address in residency country, (e) Tax Identification Number of residency country (f) a certificate of his being resident in any country or specified territory outside India from the Government of that country or specified territory if the law of that country or specified territory provides for issuance of such certificate. It is recommended that shareholders should independently satisfy their eligibility to claim DTAA benefit including meeting of all conditions laid down by DTAA. Kindly note that the Company is not obligated to apply beneficial DTAA rates at the time of tax deduction/ withholding on dividend amounts. Application of beneficial rate as per DTAA for the purpose of withholding taxes shall depend upon completeness and satisfactory review by the Company of the documents submitted by non-resident shareholder. Soft copies of following documents may be downloaded from the link below: https://ipostatus.integratedregistry.in/TaxExemptionRegistration.aspx 1) Form 121 (erstwhile form 15G and form 15H) 2) Online Form 41 3) Declaration from residents 4) Declaration from non-residents (no Permanent Establishment in India and Beneficial ownership) 5) Declaration under Rule 217 from non-residents (other than companies) not having PAN Duly filled and signed aforesaid documents, as applicable, should be uploaded only on weblink of RTA viz., https://ipostatus.integratedregistry.in/TaxExemptionRegistration.aspx latest , by July 31, 2026 2026, 17:00 hrs IST, to enable the Company to determine the appropriate TDS/ withholding tax rate applicable. Kindly note that exemptions forms submitted to any other emai [Showing first 8,000 characters — download PDF for full document]